Skip to content

Blood Loss Between Surgical Blade and Unipolar Electrocautery in TKA

Comparison of Blood Loss Between Surgical Blade and Unipolar Electrocautery in Primary Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02108327
Acronym
TKA
Enrollment
80
Registered
2014-04-09
Start date
2014-04-30
Completion date
2015-05-31
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss

Keywords

Blood loss, total knee arthroplasty, hot knife, cold knife, unipolar electrocautery, surgical blade

Brief summary

Using of surgical blade may have less blood loss than unipolar electrocautery in Total Knee Arthroplasty (TKA).

Interventions

Using surgical blade all the time of surgery

Using electrocautery all the time except at skin incision

Sponsors

Thammasat University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* osteoarthritis of the knee who undergoing unilateral primary total knee arthroplasty * age 50-85 years old * ASA class 1-3

Exclusion criteria

* unable to perform spinal anaesthesia * history of coagulation disorder * renal impairment (CrCl \<30 mL/min) or cirrhosis * platelet count \< 100,000 or abnormal coagulogram * on pacemaker * stop anti-platelet or anti-coagulogram less than 7 days

Design outcomes

Primary

MeasureTime frameDescription
Blood loss48 hours\- detected total blood loss from hemoglobin at 24,48 hours after surgery, maximum Hb drop and blood loss collected in radivac drain

Secondary

MeasureTime frameDescription
inflammation48 hoursdetermine inflammatory response with C-rective protein (CRP) at post-op 48 hours
Knee function3 monthsmeasured with WOMAC
knee range of motion3 months
complication2 weeksdetected with wound dehiscence, wound infection

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026